Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Ricks, Philip M ^a   Cain, Kevin P ^a   Oeltmann, John E ^a   Kammerer, J Steve ^a   Moonan, Patrick K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; NONHUMAN; RECURRENT INFECTION; RISK FACTOR; TUBERCULOSIS CONTROL; UNITED STATES; AGE DISTRIBUTION; COST OF ILLNESS; DISEASE TRANSMISSION; INCIDENCE; INFANT; MIDDLE AGED; MIGRATION; NEWBORN; PRESCHOOL CHILD; STATISTICS; TIME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; EMIGRATION AND IMMIGRATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; TIME FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 82255195399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027405     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention (2010) Reported Tuberculosis in the United States, 2009 Atlanta, GA U.S. Department of Health and Human Services, CDC.
2. Stop TB USA Tuberculosis Elimination Plan Committee (2010) A Call for Action on the Tuberculosis Elimination Plan for the United States Atlanta, GA Stop TB USA.
3. Hill A, Becerra J, Castro K, (2010) Modeling the Impact of Interventions on Tuberculosis Trends in the United States. Modeling for Public Health Action conference. CDC: Atlanta, GA.
4. Abubakar I, Lipman M, Anderson C, Davies P, Zumla A, (2011) Tuberculosis in the UK-time to regain control. BMJ 29: 343.
5. Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, et al. (2009) The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis 13 (5): 645-51.
6. Langlois-Klassen D, Wooldrage KM, Manfreda J, Sutherland K, Ellis E, et al. (2011) Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Respir J 38 (4): 895-902.
7. World Health Organization (2009) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2008 Geneva World Health Organization.
8. Centers for Disease Control and Prevention (1995) Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 44 (RR-11): 1-16.
9. Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z, (2003) Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 7 (12 Suppl 3): S384-90.
10. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, et al. (2000) Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 162 (6): 2033-8.
11. Walter ND, Jasmer RM, Grinsdale J, Kawamura LM, Hopewell PC, et al. (2008) Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective. Clin Infect Dis 46 (1): 103-106.
12. Menzies D, (2001) Controlling tuberculosis among foreign-born within industrialized countries: expensive band-aids. Am J Respir Crit Care Med 164 (6): 914-915.
13. Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, et al. (2002) Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 346 (19): 1453-1458.
14. Barnes PF, Cave MD, (2003) Molecular epidemiology of tuberculosis. N Engl J Med 349 (12): 1149-56.
15. Hernández-Garduño E, Kunimoto D, Wang L, Rodrigues M, Elwood RK, et al. (2002) Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ 167 (4): 349-352.
16. Borgdorff MW, Behr MA, Nagelkerke NJD, Hopewell PC, Small PM, (2000) Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis 4: 287-294.
17. Haddad MB, Diem LA, Cowan LS, Cave MD, Bettridge J, et al. (2007) Tuberculosis genotyping in six low-incidence States, 2000-2003. Am J Prev Med 32 (3): 239-243.
18. El Sahly H, Adams GJ, Soini H, Teeter L, Musser JM, et al. (2001) Epidemiologic Differences between United States and Foreign-Born Tuberculosis Cases in Houston, Texas. J Infect Dis 183 (3): 461-8.
19. Sharnprapai S, Miller AC, Suruki R, Corkren E, Etkind S, et al. (2002) Genotyping analyses of tuberculosis cases in U.S.- and foreign-born Massachusetts residents. Emerg Infect Dis 8 (11): 1239-1245.
20. Centers for Disease Control and Prevention (2005) New CDC program for rapid genotyping of Mycobacterium tuberculosis isolates. MMWR Morb Mortal Wkly Rep 54: 47.
21. Centers for Disease Control and Prevention (2010) Report of Verified Case of Tuberculosis (RVCT) Instruction Manual, 2009. Available: http://www.cdc.gov/tb/programs/rvct/InstructionManual.pdf. Accessed Oct 31 2011.
22. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35 (4): 907-14.
23. Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, et al. (2000) Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 36 (3): 762-71.
24. Cowan LS, Diem L, Monson T, Wand P, Temporado D, et al. (2005) Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol 43 (2): 688-95.
25. Ghosh S, Moonan PK, Cowan LS, Grant J, Kammerer JS, et al. (2011) Establishing a National Tuberculosis Genotyping Surveillance System in the United States. Infect Genet Evol (In press).
26. Kulldorff M, (1997) A spatial scan statistic. Commun Stat-Theor M 26 (6): 1481-96.
27. Centers for Disease Control and Prevention (2005) Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 54 (RR-12): 1-84.
28. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG, (1997) Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 278 (4): 304-7.
29. Talbot EA, Moore M, McCray E, Binkin NJ, (2000) Tuberculosis Among Foreign-Born Persons in the United States, 1993-1998. JAMA 284 (22): 2894-2900.
30. Cain KP, Benoit SR, Winston CA, Mac Kenzie WR, (2008) Tuberculosis among foreign-born persons in the United States. JAMA 300 (4): 405-412.
31. World Health Organization (2011) Global tuberculosis control- epidemiology, strategy, financing: WHO Report 2010.WHO\HTM\TB\2010.411 Geneva, Switzerland WHO.
32. Oppong JR, Denton CJ, Moonan PK, Weis SE, (2007) Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas. Prof Geogr 59 (4): 478-491.
33. Love J, Sonnenberg P, Glynn JR, Gibson A, Gopaul K, et al. (2009) Molecular epidemiology of tuberculosis in England, 1998. Int J Tuberc Lung Dis 13: 201-7.
34. Barniol J, Niemann S, Louis VR, Brodhun B, Dreweck C, et al. (2009) Transmission dynamics of pulmonary tuberculosis between autochthonous andimmigrant sub-populations. BMC Infect Dis 9: 197.
35. Centers for Disease Control and Prevention (2009) CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment, Using Cultures and Directly Observed Therapy Atlanta, GA U.S. Department of Health and Human Services.
36. Centers for Disease Control and Prevention (1991) Technical Instructions For Medical Examination Of Aliens Atlanta, GA U.S. Department of Health and Human Services.
37. American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-S247.
38. Schwartzman K, Oxlade O, Barr RG, Grimard F, Acosta I, et al. (2005) Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 353 (10): 1008-20.
39. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW, (2008) Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 12 (11): 1235-54.
40. Sterling TR, (2010) The PREVENT TB Study (TB Trials Consortium Study 26): 3 months of once-weekly rifapentine plus INH vs. 9 months of daily INH for treatment of latent TB infection: First report of results of a multi-center, randomized clinical trial. Available:http://www.worldlunghealth.org/confBerlin/images/stories/PDF/final%20programme%202010-entier.pdf. Accessed 31 Oct 2011.
41. Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, et al. (2006) Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 173: 922-926.
42. Sandegren L, Groenheit R, Koivula T, Ghebremichael S, Advani A, et al. (2011) Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden. PLoS One 6 (1): e16647.
43. Savine-Warren RM, van der Spuy GD, Beyers G, van Helden PD, Locht C, et al. (2002) Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis. J Clin Microbiol 40 (12): 4561-6.
44. Linas BP, Wong AY, Freedberg KA, Horsburgh CR Jr, (2011) Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States. Am J Respir Crit Care Med 184: 590-601.
45. Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, et al. (2011) Screening of immigrants in the UK for imported latent tuberculosis: a multicentrecohort study and cost-effectiveness analysis. Lancet Infect Dis 11 (6): 435-44.
46. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A, (2009) Comparative Performance of Tuberculin Skim Testing, Quanitferon-TB-Gold In Tube Assay and T-spot.TB Tets in Contact Investigations for Tuberculosis. Chest 135 (4): 1010-8.
47. Oxlade O, Schwartzman K, Menzies D, (2007) Interferon-gamma release assays and tuberculosis screening in high income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 11 (1): 16-26.